Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00546728 · ClinicalTrials.gov registry record · Phase 4
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
A Phase 4 study, sponsored by St. Paul Heart Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00546728 is a Phase 4 study that has completed, run by St. Paul Heart Clinic. The registered enrollment target is 50 participants.
The verdict
NCT00546728, a Phase 4 study, has completed, sponsored by St. Paul Heart Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of exenatide versus metformin on vascular health with chronic (3-month) therapy and during a 2-hour period following a meal in patients with pre-diabetes. It is predicted that exenatide will improve vascular health to a greater degree compared to metformin.
Interventions
- DRUG Metformin
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00546728
The ClinicalTrials.gov registry entry for NCT00546728 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Paul Heart Clinic, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT00546728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00546728 about?
NCT00546728 is a clinical study titled "The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes". The purpose of this study is to compare the effects of exenatide versus metformin on vascular health with chronic (3-month) therapy and during a 2-hour period following a meal in patients with pre-diabetes. It is predicted that exenatide will improve vascular health to a greater degree compared to m...
What is the current status of trial NCT00546728?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2007-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00546728?
The interventions under investigation include: Metformin (DRUG), Exenatide (DRUG).
Who is sponsoring clinical trial NCT00546728?
This trial is sponsored by St. Paul Heart Clinic, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.